Latest clinical trials News | Page 2

Milestone For MRNA Manufacturing Facility
Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
Magic mushrooms and Alzheimer’s: what one remarkable case can tell us
Why some men with prostate cancer may soon need only five radiotherapy sessions
Cairns Hospital Expansion progresses as tender release paves the way for more healthcare in FNQ
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
World-Leading Biomedical Research Centre Opens In Victoria
Insular cortex linked to brain stimulation’s antidepressant effects
Message by the Director of the Department of Immunization, Vaccines and Biologicals at WHO – May 2026
Three KI Projects On 2026 IVA Research Impact List
We Stand With Daniher Family To Defeat Beast
Expanding Access to Enzalutamide for Prostate Cancer Patients
EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York
Priority Aged Care Support For Australians With MND
‘Incredible’ Hodgkin Lymphoma Clinical Trial Study
Women with kidney disease are being undertested, undertreated and left behind by decades of male-dominated research
Priority Aged Care Support For Australians With MND
Colgate-Palmolive renews University’s oldest business partnership
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease
Driving innovation in stroke care and sustainable clinical trials
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?
Central Coast Cancer Centre plays leading role in pioneering liver cancer clinical trial using AI
Can Wegovy move the needle on NZ’s obesity crisis, or simply treat its symptoms?
Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus
QIMR Berghofer and TFBS Bioscience sign MOU to advance cell and gene therapies
Icon Cancer Centre steps up for men and their families impacted by prostate cancer
Landmark approval of Tzield in Australia ushers in a new era of delay for type 1 diabetes
How a remarkable trial on bedrest during the Korean war helped lead to evidence-based medicine
Victoria University Opens New Research Building
Victorian Premier Issues Statement 25 May
First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo…
Childhood, Adolescent and Young Adult Cancer Roadmap Release
Datroway approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who…
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive metastatic solid tumours
Why does motor neurone disease take so long to diagnose? And can it be treated?
Delivering World Class Health And Medical Research For Australia
New radiochemical lab to support next-gen cancer treatment
Prescriptions for ivermectin soar after Mel Gibson claims it cured friends of cancer
Can supplements containing NMN, NAD+ and resveratrol really slow ageing? Here’s what the evidence says
Clinical Trials Day highlights the key role of WA’s researchers
Behind Scenes Of 10 Year Global Clinical Trial
A pill helps you keep weight off after you come off weight-loss jabs – new study
International Clinical Trials Day highlights importance of investing in medical research
Queensland Government lures biomed business and jobs to Queensland
Advances In Diagnosis And Treatment
What you need to know about the Ebola outbreak that has the WHO concerned
Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency…
Federal Budget commitment to medical research funding welcome, but urgent need for gynaecological cancer investment remains